Exchange: NASDAQ·Updated 03:39 PM EDT
ITRM logo

ITRM Iterum Therapeutics Plc

$0.00
$0.00
(0.00%)
Today
Reported EarningsNov 14
Mkt Cap$53.00
Vol33.00

About ITRM

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
49

Neutral Sentiment

How do you feel about ITRM?

Advertisement|Remove ads.